Stockreport

Gyre Therapeutics GAAP EPS of -$0.02 misses by $0.09, revenue of $37.2M beats by $1.76M [Seeking Alpha]

Gyre Therapeutics, Inc.  (GYRE) 
PDF Full year 2026 revenue guidance of $100.5 to $111.0 million Newsletters for Every Investor Get daily, sector-specific newsletters packed with expert insights, fresh [Read more]